Related references
Note: Only part of the references are listed.Polo-Like-Kinase 1 Is a Proviral Host Factor for Hepatitis B Virus Replication
Ahmed Diab et al.
HEPATOLOGY (2017)
Sodium Taurocholate Cotransporting Polypeptide Is the Limiting Host Factor of Hepatitis B Virus Infection in Macaque and Pig Hepatocytes
Florian A. Lempp et al.
HEPATOLOGY (2017)
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
Satomi Shimura et al.
JOURNAL OF HEPATOLOGY (2017)
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Joanne M. Donkers et al.
SCIENTIFIC REPORTS (2017)
Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells
Ming Zhou et al.
VIROLOGICA SINICA (2017)
Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA
Chunlan Liu et al.
ANTIVIRAL RESEARCH (2016)
Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential
Maura Dandri et al.
CLINICAL INFECTIOUS DISEASES (2016)
Early events in hepatitis B virus infection: From the cell surface to the nucleus
C. Nelson Hayes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Oxethazaine inhibits hepatitis B virus capsid assembly by blocking the cytosolic calcium-signalling pathway
Lin Zhang et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice
Yuji Ishida et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
Xue-jun Wang et al.
ANTIVIRAL RESEARCH (2015)
Pretreatment with Evans blue, a stimulator of BKCa channels, inhibits compound 48/80-induced shock, systemic inflammation, and mast cell degranulation in the rat
Yaw-Syan Fu et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2015)
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
Manabu Kaneko et al.
JOURNAL OF VIROLOGY (2015)
Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
Ran Yan et al.
PLOS ONE (2015)
Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression
Senko Tsukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes
Hsiu-Chen Huang et al.
ANTIVIRAL RESEARCH (2014)
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
Matthieu Blanchet et al.
ANTIVIRAL RESEARCH (2014)
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
Masashi Iwamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes
Alexander Koenig et al.
JOURNAL OF HEPATOLOGY (2014)
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
Shirin Nkongolo et al.
JOURNAL OF HEPATOLOGY (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
Julie Lucifora et al.
ANTIVIRAL RESEARCH (2013)
Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide
Huan Yan et al.
JOURNAL OF VIROLOGY (2013)
Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
Dawei Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Cyclin-Dependent Kinase 2 Phosphorylates S/T-P Sites in the Hepadnavirus Core Protein C-Terminal Domain and Is Incorporated into Viral Capsids
Laurie Ludgate et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction
Xin Geng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
HBV life cycle and novel drug targets
Daniel Grimm et al.
HEPATOLOGY INTERNATIONAL (2011)
The natural history of chronic HBV infection and geographical differences
Yun-Fan Liaw et al.
ANTIVIRAL THERAPY (2010)
The replication cycle of hepatitis B virus
Stephan Urban et al.
JOURNAL OF HEPATOLOGY (2010)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
Viral and cellular determinants involved in hepadnaviral entry
Dieter Glebe et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Involvement of endoplasmic reticulum in hepatitis B virus replication
Weiliang Xia et al.
VIRUS RESEARCH (2006)
Fluorescence imaging of blood-brain barrier disruption
BT Hawkins et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Calcium ions affect the hepatitis B virus core assembly
YW Choi et al.
VIROLOGY (2005)
Evans Blue and other dyes as protein tyrosine phosphatase inhibitors
S Shrestha et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
DJ Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Infection of a human hepatoma cell line by hepatitis B virus
P Gripon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability
PW Hamer et al.
JOURNAL OF ANATOMY (2002)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
